Nan Shan Life Insurance’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
VCM
VPM
Nan Shan Life Insurance's PFE Position: Q1 2026 in Review
Nan Shan Life Insurance increased its Pfizer (PFE) stake by 74% in Q1 2026, buying an estimated $34.7M and bringing the position to 3,070,309 shares worth $86.2M. The position accounts for 3.12% of the portfolio, ranked #9.
Nan Shan Life Insurance first reported a position in PFE in Q2 2024 and has held it in 8 quarters since. 2,934 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Nan Shan Life Insurance held 3,070,309 shares of Pfizer worth $86.2M as of Q1 2026.
- Nan Shan Life Insurance bought 1,301,657 Pfizer shares in Q1 2026, an estimated $34.7M.
- Pfizer made up 3.12% of Nan Shan Life Insurance's portfolio in Q1 2026, its #9 holding.
- Nan Shan Life Insurance first reported a position in Pfizer in Q2 2024 and has held it in 8 quarters since.
- 2,934 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Nan Shan Life Insurance's 13F filing for Q1 2026, filed 14 May 2026.